retatrutide phase 2 obesity nejm 2023 jastreboff vs. Ozempic: The Triple Agonist That May Change Everything., Semaglutide hits one receptor. Retatrutide hits three., That difference may be the biggest leap in metabolic medicine since , This data from Phase 3

Rosa EF, Ribeiro RF, Pereira FM, Freymller E, Aboulafia J, Nouailhetas VL

Comparing vial longevity across GLP-1 medications How does tirzepatide vial longevity compare to other GLP-1 receptor agonists

A placebo-controlled clinical trial demonstrated that a peptide serum containing SNAP-8 led to a significant reduction in expression lines and overall improvement in skin texture

Taking vitamin B12 injections completely bypasses any digestive absorption issues and consequently get the vitamins to where they are needed

Reduction in Systemic Inflammation Chronic inflammation, reflected by elevated CRP and TNF-, interferes with reproductive hormone signaling